NME1 and colon carcinoma: NME1 has been identified as the first metastasis suppressor, showing reduced expression in high melanoma metastatic cells and as a suppressor of breast, liver, and colon carcinoma metastasis through mechanisms that are not yet well-understood (Steeg et al., 1988; Boissan et al., 2005).